IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v2y2018i1d10.1007_s41669-017-0034-3.html
   My bibliography  Save this article

Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire

Author

Listed:
  • Theodora Oikonomidi

    (University of Athens)

  • Michail Vikelis

    (Glyfada Headache Clinic
    Mediterraneo Hospital)

  • Artemios Artemiadis

    (University of Athens)

  • George P. Chrousos

    (University of Athens
    University of Athens)

  • Christina Darviri

    (University of Athens)

Abstract

Background The Migraine Disability Assessment (MIDAS) Questionnaire is a reliable and valid instrument for migraine-related disability. Such a tool is needed to quantify migraine-related disability in the Greek population. Objective This validation study aims to assess the test–retest reliability, internal consistency, item discriminant and convergent validity of the Greek translation of the MIDAS. Methods Adults diagnosed with migraine completed the MIDAS Questionnaire on two occasions 3 weeks apart to assess reliability, and completed the RAND-36 to assess validity. Results Participants (n = 152) had a median MIDAS score of 24 and mostly severe disability (58% were grade IV). The test–retest reliability analysis (N = 59) revealed excellent reliability for the total score. Internal consistency was α = 0.71 for initial and α = 0.82 for retest completion. For item discriminant validity, the correlations between each question and the total score were significant, with high correlations for questions 2–5 (range 0.67 ≤ r ≤ 0.79; p

Suggested Citation

  • Theodora Oikonomidi & Michail Vikelis & Artemios Artemiadis & George P. Chrousos & Christina Darviri, 2018. "Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire," PharmacoEconomics - Open, Springer, vol. 2(1), pages 77-85, March.
  • Handle: RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0034-3
    DOI: 10.1007/s41669-017-0034-3
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-017-0034-3
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1007/s41669-017-0034-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0034-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.